Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cholesterol
cholesterol
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
BioSpace
Thu, 02/15/24 - 11:40 am
Vaxxinity
VXX-401
vaccines
cholesterol
Lilly’s Cholesterol Pill Shows Early Promise in Phase I Study
BioSpace
Tue, 08/29/23 - 11:15 am
Eli Lilly
muvalaplin
clinical trials
cholesterol
Merck bets big on oral PCSK9 inhibitor, putting 6-year outcome study at heart of phase 3 program
Fierce Biotech
Fri, 08/25/23 - 09:57 am
Merck
PCSK9 inhibitors
clinical trials
cardiovascular disease
cholesterol
MK-0616
Cholesterol-focused Esperion loses appetite for oral PCSK9 collab with Serometrix
Fierce Biotech
Tue, 08/1/23 - 11:57 am
Esperion Therapeutics
R&D
Serometrixjm
PCSK9 inhibitors
cholesterol
ACC 2023 – Esperion’s outcomes win looks lacklustre
EP Vantage
Mon, 03/6/23 - 10:45 am
Esperion Therapeutics
ACC
Nexletol
cholesterol
Abionyx hails success of bid to resurrect failed cholesterol drug—without dishing data to back up claims
Fierce Biotech
Tue, 01/17/23 - 10:14 am
Abionyx
clinical trials
cholesterol
CER-001
AstraZeneca dumps Ionis drug despite hit in phase 2 cholesterol trial
Fierce Biotech
Fri, 09/23/22 - 11:00 am
AstraZeneca
Ionis Pharmaceuticals
clinical trials
ION449
cholesterol
Drugmakers leap back into fading heart drug market
Beckers Hospital Review
Thu, 07/28/22 - 06:40 pm
Bristol Myers Squibb
Novartis
Merck
Alnylam Pharmaceuticals
Amgen
hypertension
cholesterol
ACC 2022 – Astra’s cholesterol lowerer surprise comes just a little late
EP Vantage
Tue, 04/5/22 - 10:59 am
AstraZeneca
Ionis Pharmaceuticals
AZD8233
cholesterol
ACC
Amgen
Sanofi
Novartis
Regeneron
Can A New Cholesterol Drug Restore Merck’s Prominence In Heart Drugs?
Forbes
Tue, 02/1/22 - 10:48 am
Merck
cholesterol
PCSK9 inhibitors
MK-0616
Zocor
Pfizer ends $3B drug dream despite phase 2b success, leaving Regeneron with a clear run at cardiovascular market
Fierce Biotech
Mon, 01/31/22 - 10:47 am
Pfizer
vupanorsen
Ionis Pharmaceuticals
cholesterol
It Was To Be The Cholesterol Drug For The Masses. Novartis Changed That.
Forbes
Mon, 01/3/22 - 10:42 am
Novartis
inclisiran
Leqvio
cholesterol
Novartis wins FDA approval for new heart drug, but faces uphill sales battle
BioPharma Dive
Wed, 12/22/21 - 11:35 pm
Novartis
FDA
Leqvio
cholesterol
Novartis finalizes deal to make new heart drug widely available in England
BioPharma Dive
Wed, 09/1/21 - 10:55 pm
UK
Novartis
Leqvio
heart disease
cholesterol
What if a pill could lower cholesterol like pricey injectables? Esperion intends to find out
Stat
Wed, 01/13/21 - 10:36 am
Esperion Therapeutics
cholesterol
Serometrix
FDA Refuses to Approve Novartis' $9.7 Billion Cholesterol Drug for Now
Motley Fool
Sat, 12/19/20 - 11:41 pm
Novartis
FDA
cholesterol
inclisiran
complete response letter
Novartis’s big wager on RNAi approaches the finish line
EP Vantage
Wed, 11/25/20 - 10:27 am
Novartis
RNAi
COVID-19
Leqvio
cholesterol
Ionis and Akcea announce that Pfizer initiated clinical study of vupanorsen
Pharmaceutical Business Review
Wed, 11/4/20 - 10:13 am
Ionis Pharmaceuticals
Akcea Therapeutics
Pfizer
clinical trials
vupanorsen
cholesterol
AZ buys oral PCSK9 cholesterol drug from Dogma Therapeutics
Pharmaforum
Thu, 09/17/20 - 10:38 am
AstraZeneca
Dogma Therapeutics
cholesterol
PCSK9 inhibitors
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
Fierce Pharma
Sun, 08/30/20 - 11:25 pm
ESC
Amgen
Repatha
Sanofi
Regeneron
Praluent
cholesterol
Pages
1
2
3
4
5
6
7
next ›
last »